TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2008: $32.18M2009: $23.50M2010: $38.05M2011: $34.59M2012: $71.14M2013: $51.39M2014: $51.20M2015: $45.30M2016: $56.56M2017: $99.42M2018: $95.45M2019: $75.40M2020: $259.80M2021: $235.00M2022: $204.70M2023: $200.40M2024: $297.70M2025: $437.60M$437.60M
2008Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$437.60M+47.0%
2024$297.70M+48.6%
2023$200.40M-2.1%
2022$204.70M-12.9%
2021$235.00M-9.5%
2020$259.80M+244.6%
2019$75.40M-21.0%
2018$95.45M-4.0%
2017$99.42M+75.8%
2016$56.56M+24.9%
2015$45.30M-11.5%
2014$51.20M-0.4%
2013$51.39M-27.8%
2012$71.14M+105.6%
2011$34.59M-9.1%
2010$38.05M+62.0%
2009$23.50M-27.0%
2008$32.18M—